For all the hype around artificial intelligence, its potential benefits to the pathology industry are unmistakable.
“Digital pathology is something that will be hitting us in a big way very, very soon,” said chief executive Colin Goldschmidt at a recent investor briefing. “AI itself is going to apply to our Lab division and our radiology division and will provide us with step changes in efficiency, quality and capacity.”
Sonic Healthcare bought a 20% stake in AI developer Harrison.ai a few years ago, with the aim
